LURASIDONE

Clinical Indication

Schizophrenia aged 13-17 years

Comments

Full SCA  Request form

Date of classification

November 2017

Review date

November 2021

Orange

Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.